RNA content in the nucleolus alters p53 acetylation via MYBBP1A

A number of external and internal insults disrupt nucleolar structure, and the resulting nucleolar stress stabilizes and activates p53. We show here that nucleolar disruption induces acetylation and accumulation of p53 without phosphorylation. We identified three nucleolar proteins, MYBBP1A, RPL5, and RPL11, involved in p53 acetylation and accumulation. MYBBP1A was tethered to the nucleolus through nucleolar RNA. When rRNA transcription was suppressed by nucleolar stress, MYBBP1A translocated to the nucleoplasm and facilitated p53–p300 interaction to enhance p53 acetylation. We also found that RPL5 and RPL11 were required for rRNA export from the nucleolus. Depletion of RPL5 or RPL11 blocked rRNA export and counteracted reduction of nucleolar RNA levels caused by inhibition of rRNA transcription. As a result, RPL5 or RPL11 depletion inhibited MYBBP1A translocation and p53 activation. Our observations indicated that a dynamic equilibrium between RNA generation and export regulated nucleolar RNA content. Perturbation of this balance by nucleolar stress altered the nucleolar RNA content and modulated p53 activity.

[1]  J. Qin,et al.  Negative regulation of the deacetylase SIRT1 by DBC1 , 2008, Nature.

[2]  Ken Chen,et al.  The Ink4a Tumor Suppressor Gene Product, p19Arf, Interacts with MDM2 and Neutralizes MDM2's Inhibition of p53 , 1998, Cell.

[3]  R J DUBOS,et al.  Health and disease. , 1960, JAMA.

[4]  Sam W. Lee,et al.  Hzf Determines Cell Survival upon Genotoxic Stress by Modulating p53 Transactivation , 2007, Cell.

[5]  Yi Tang,et al.  Acetylation Is Indispensable for p53 Activation , 2008, Cell.

[6]  Yoichi Taya,et al.  DNA Damage-Induced Phosphorylation of p53 Alleviates Inhibition by MDM2 , 1997, Cell.

[7]  O. Koroleva,et al.  Assembly of 5S Ribosomal RNA Is Required at a Specific Step of the Pre-rRNA Processing Pathway , 1999, The Journal of cell biology.

[8]  M. Oren,et al.  The p53-Mdm2 module and the ubiquitin system. , 2003, Seminars in cancer biology.

[9]  Anthony K. L. Leung,et al.  Nucleolar proteome dynamics , 2005, Nature.

[10]  K. Sakaguchi,et al.  DNA damage activates p53 through a phosphorylation-acetylation cascade. , 1998, Genes & development.

[11]  E. Casanova,et al.  Genetic inactivation of the transcription factor TIF-IA leads to nucleolar disruption, cell cycle arrest, and p53-mediated apoptosis. , 2005, Molecular cell.

[12]  Delin Chen,et al.  Deacetylation of p53 modulates its effect on cell growth and apoptosis , 2000, Nature.

[13]  E. Cheung,et al.  MYBBP1a is a Novel Repressor of NF-κB , 2007 .

[14]  Xin Cai,et al.  An acetylation switch in p53 mediates holo-TFIID recruitment. , 2007, Molecular cell.

[15]  M. Okuwaki,et al.  [Structure and function of the nucleolus]. , 2006, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme.

[16]  Xiaolong Wei,et al.  Human MUC1 oncoprotein regulates p53-responsive gene transcription in the genotoxic stress response. , 2005, Cancer cell.

[17]  K. Mizuta,et al.  Synergistic defect in 60S ribosomal subunit assembly caused by a mutation of Rrs1p, a ribosomal protein L11-binding protein, and 3′-extension of 5S rRNA in Saccharomyces cerevisiae , 2005, Nucleic acids research.

[18]  C. Carlberg,et al.  The Human Hyaluronan Synthase 2 Gene Is a Primary Retinoic Acid and Epidermal Growth Factor Responding Gene* , 2005, Journal of Biological Chemistry.

[19]  E. Appella,et al.  Post-translational modifications and activation of p53 by genotoxic stresses. , 2001, European journal of biochemistry.

[20]  T. Gonda,et al.  Detection of proteins that bind to the leucine zipper motif of c-Myb. , 1994, Oncogene.

[21]  I. Grummt,et al.  The nucleolus as a stress sensor: JNK2 inactivates the transcription factor TIF-IA and down-regulates rRNA synthesis. , 2005, Genes & development.

[22]  E. Appella,et al.  Phosphorylation Site Interdependence of Human p53 Post-translational Modifications in Response to Stress* , 2003, Journal of Biological Chemistry.

[23]  E. Cheung,et al.  MYBBP1a is a novel repressor of NF-kappaB. , 2007, Journal of molecular biology.

[24]  D. Gilbert,et al.  Molecular Cloning Reveals that the p160 Myb-Binding Protein Is a Novel, Predominantly Nucleolar Protein Which May Play a Role in Transactivation by Myb , 1998, Molecular and Cellular Biology.

[25]  V. Díaz,et al.  Myb-Binding Protein Interacts with Prep 1 and Inhibits Its Transcriptional Activity † , 2007 .

[26]  Wei Gu,et al.  Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation. , 2003, Current opinion in cell biology.

[27]  Pier Paolo Pandolfi,et al.  Nucleophosmin and cancer , 2006, Nature Reviews Cancer.

[28]  Leena Latonen,et al.  Nucleolar protein NPM interacts with HDM2 and protects tumor suppressor protein p53 from HDM2-mediated degradation. , 2004, Cancer cell.

[29]  Ettore Appella,et al.  p300/CBP‐mediated p53 acetylation is commonly induced by p53‐activating agents and inhibited by MDM2 , 2001, The EMBO journal.

[30]  P. Herrlich,et al.  DNA damage induced p53 stabilization: no indication for an involvement of p53 phosphorylation , 1999, Oncogene.

[31]  Hong Yang,et al.  Phosphorylation of p53 on Key Serines Is Dispensable for Transcriptional Activation and Apoptosis*♦ , 2004, Journal of Biological Chemistry.

[32]  J. Steitz,et al.  A 5S rRNA/L5 complex is a precursor to ribosome assembly in mammalian cells , 1988, The Journal of cell biology.

[33]  C. Prives,et al.  Excess HDM2 Impacts Cell Cycle and Apoptosis and Has a Selective Effect on p53-dependent Transcription* , 2006, Journal of Biological Chemistry.

[34]  E. Stavridi,et al.  Phosphorylation of Ser-20 mediates stabilization of human p53 in response to DNA damage. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[35]  S. Ishii,et al.  Ribosomal stress induces processing of Mybbp1a and its translocation from the nucleolus to the nucleoplasm , 2007, Genes to cells : devoted to molecular & cellular mechanisms.

[36]  I. Grummt,et al.  Cellular Stress and Nucleolar Function , 2005, Cell cycle.

[37]  C. Carlberg,et al.  Regulation of the human cyclin C gene via multiple vitamin D3-responsive regions in its promoter , 2005, Nucleic acids research.

[38]  Junjie Chen,et al.  DBC1 is a negative regulator of SIRT1 , 2008, Nature.

[39]  T. Allio,et al.  Ribosomal Protein L11 Negatively Regulates Oncoprotein MDM2 and Mediates a p53-Dependent Ribosomal-Stress Checkpoint Pathway , 2003, Molecular and Cellular Biology.

[40]  Wei Gu,et al.  Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain , 1997, Cell.

[41]  K. Itahana,et al.  Inhibition of HDM2 and Activation of p53 by Ribosomal Protein L23 , 2004, Molecular and Cellular Biology.

[42]  Nobuko Katoku-Kikyo,et al.  Reversible disassembly of somatic nucleoli by the germ cell proteins FRGY2a and FRGY2b , 2003, Nature Cell Biology.

[43]  Andrew A. Quong,et al.  Distinct p53 acetylation cassettes differentially influence gene-expression patterns and cell fate , 2006, The Journal of cell biology.

[44]  Xin Lu,et al.  ASPP and cancer , 2006, Nature Reviews Cancer.

[45]  K. Vousden,et al.  Stress Signals Utilize Multiple Pathways To Stabilize p53 , 2000, Molecular and Cellular Biology.

[46]  R. Nazar,et al.  Unbalanced ribosome assembly in Saccharomyces cerevisiae expressing mutant 5 S rRNAs. , 1992, The Journal of biological chemistry.

[47]  D. Hernandez-Verdun,et al.  Initiation of nucleolar assembly is independent of RNA polymerase I transcription. , 2000, Molecular biology of the cell.

[48]  Chad Deisenroth,et al.  Cancer-Associated Mutations in the MDM2 Zinc Finger Domain Disrupt Ribosomal Protein Interaction and Attenuate MDM2-Induced p53 Degradation , 2006, Molecular and Cellular Biology.

[49]  A. Levine.  p53, the Cellular Gatekeeper for Growth and Division , 1997, Cell.

[50]  Wei Gu,et al.  p53 ubiquitination: Mdm2 and beyond. , 2006, Molecular cell.

[51]  J. Whitlock,et al.  Myb-binding Protein 1a Augments AhR-dependent Gene Expression* , 2002, The Journal of Biological Chemistry.

[52]  F. He,et al.  KRAB-type zinc-finger protein Apak specifically regulates p53-dependent apoptosis , 2009, Nature Cell Biology.

[53]  F. Kashanchi,et al.  Phosphorylation of p53 Serine 15 Increases Interaction with CBP* , 1998, The Journal of Biological Chemistry.

[54]  W. Wang,et al.  Ribosomal protein S7 as a novel modulator of p53–MDM2 interaction: binding to MDM2, stabilization of p53 protein, and activation of p53 function , 2007, Oncogene.

[55]  E. Appella,et al.  Mutation of Mouse p53 Ser23 and the Response to DNA Damage , 2002, Molecular and Cellular Biology.

[56]  C. Banwell,et al.  Regulation of the human p21(waf1/cip1) gene promoter via multiple binding sites for p53 and the vitamin D3 receptor , 2006, Nucleic acids research.

[57]  V. Díaz,et al.  p160 Myb-Binding Protein Interacts with Prep1 and Inhibits Its Transcriptional Activity , 2007, Molecular and Cellular Biology.

[58]  K. Bhat,et al.  Essential role of ribosomal protein L11 in mediating growth inhibition‐induced p53 activation , 2004, The EMBO journal.

[59]  M. Dai,et al.  Inhibition of MDM2-mediated p53 Ubiquitination and Degradation by Ribosomal Protein L5* , 2004, Journal of Biological Chemistry.

[60]  Muyang Li,et al.  Acetylation of p53 Inhibits Its Ubiquitination by Mdm2* , 2002, The Journal of Biological Chemistry.

[61]  W. Gu,et al.  Acetylation of p53 augments its site-specific DNA binding both in vitro and in vivo. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[62]  M. Dai,et al.  Aberrant Expression of Nucleostemin Activates p53 and Induces Cell Cycle Arrest via Inhibition of MDM2 , 2008, Molecular and Cellular Biology.

[63]  C. Prives,et al.  The p53 pathway , 1999, The Journal of pathology.

[64]  Karen H. Vousden,et al.  p53 in health and disease , 2007, Nature Reviews Molecular Cell Biology.

[65]  Xin Lu,et al.  ASPP proteins specifically stimulate the apoptotic function of p53. , 2001, Molecular cell.

[66]  R. Weinberg,et al.  hSIR2SIRT1 Functions as an NAD-Dependent p53 Deacetylase , 2001, Cell.

[67]  Y Taya,et al.  DNA damage induces phosphorylation of the amino terminus of p53. , 1997, Genes & development.

[68]  G. Almouzni,et al.  The Ribosomal RNA Processing Machinery Is Recruited to the Nucleolar Domain before RNA Polymerase I during Xenopus laevis Development , 2000, The Journal of cell biology.

[69]  M. Kubbutat,et al.  Regulation of p53 Function and Stability by Phosphorylation , 1999, Molecular and Cellular Biology.

[70]  M. Dai,et al.  Ribosomal Protein L23 Activates p53 by Inhibiting MDM2 Function in Response to Ribosomal Perturbation but Not to Translation Inhibition , 2004, Molecular and Cellular Biology.

[71]  D. Meek,et al.  Serine 15 phosphorylation stimulates p53 transactivation but does not directly influence interaction with HDM2 , 1999, The EMBO journal.

[72]  S. Berger,et al.  Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases. , 2001, Molecular cell.

[73]  F. Zindy,et al.  Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[74]  Yoshiharu Kawaguchi,et al.  MDM2–HDAC1‐mediated deacetylation of p53 is required for its degradation , 2002, The EMBO journal.

[75]  K. Oishi,et al.  Molecular characterization of Mybbp1a as a co-repressor on the Period2 promoter , 2008, Nucleic acids research.

[76]  Zigang Dong,et al.  Post-translational modification of p53 in tumorigenesis , 2004, Nature Reviews Cancer.

[77]  N. Kikyo,et al.  Requirement of the Protein B23 for Nucleolar Disassembly Induced by the FRGY2a Family Proteins* , 2006, Journal of Biological Chemistry.

[78]  A. Levine,et al.  A Chromatin-associated and Transcriptionally Inactive p53-Mdm2 Complex Occurs in mdm2 SNP309 Homozygous Cells* , 2005, Journal of Biological Chemistry.

[79]  C. Prives,et al.  Blinded by the Light: The Growing Complexity of p53 , 2009, Cell.

[80]  C. Taylor,et al.  Nucleolar protein p120 contains an arginine-rich domain that binds to ribosomal RNA. , 1998, The Biochemical journal.

[81]  M. Kumeta,et al.  Proteomic and targeted analytical identification of BXDC1 and EBNA1BP2 as dynamic scaffold proteins in the nucleolus , 2009, Genes to cells : devoted to molecular & cellular mechanisms.

[82]  M. Oren,et al.  The RING domain of Mdm2 mediates histone ubiquitylation and transcriptional repression. , 2004, Molecular cell.

[83]  M. Thiry,et al.  A protocol for studying the kinetics of RNA within cultured cells: application to ribosomal RNA , 2008, Nature Protocols.

[84]  Delin Chen,et al.  Negative Control of p53 by Sir2α Promotes Cell Survival under Stress , 2001, Cell.

[85]  K. Vousden,et al.  Cooperation between the ribosomal proteins L5 and L11 in the p53 pathway , 2008, Oncogene.

[86]  Jiandie D. Lin,et al.  Suppression of mitochondrial respiration through recruitment of p160 myb binding protein to PGC-1alpha: modulation by p38 MAPK. , 2004, Genes & development.

[87]  A. Saxena,et al.  Nucleolin inhibits Hdm2 by multiple pathways leading to p53 stabilization , 2006, Oncogene.

[88]  Wei Gu,et al.  Modes of p53 Regulation , 2009, Cell.

[89]  B. O’Malley,et al.  DEAD-box RNA helicase subunits of the Drosha complex are required for processing of rRNA and a subset of microRNAs , 2007, Nature Cell Biology.

[90]  G. Wahl,et al.  The C-terminal lysines fine-tune P53 stress responses in a mouse model but are not required for stability control or transactivation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[91]  J. Milner,et al.  Disruption of the nucleolus mediates stabilization of p53 in response to DNA damage and other stresses , 2003, The EMBO journal.

[92]  T. Unger,et al.  Critical role for Ser20 of human p53 in the negative regulation of p53 by Mdm2 , 1999, The EMBO journal.

[93]  L. Guarente,et al.  Negative control of p53 by Sir2alpha promotes cell survival under stress. , 2001, Cell.

[94]  Xin Lu,et al.  ASPP [corrected] and cancer. , 2006, Nature reviews. Cancer.

[95]  I. Takenaka,et al.  Regulation of the Sequence-specific DNA Binding Function of p53 by Protein Kinase C and Protein Phosphatases (*) , 1995, The Journal of Biological Chemistry.

[96]  C. Prives,et al.  hCAS/CSE1L Associates with Chromatin and Regulates Expression of Select p53 Target Genes , 2007, Cell.

[97]  U. Scheer,et al.  The nucleolus. , 1994, Current opinion in cell biology.

[98]  A. Levine,et al.  The ribosomal L5 protein is associated with mdm-2 and mdm-2-p53 complexes , 1994, Molecular and cellular biology.

[99]  T. Hughes,et al.  Assembly factors Rpf2 and Rrs1 recruit 5S rRNA and ribosomal proteins rpL5 and rpL11 into nascent ribosomes. , 2007, Genes & development.

[100]  P. Spierer,et al.  Stoichiometry, cooperativity, and stability of interactions between 5S RNA and proteins L5, L18, and L25 from the 50S ribosomal subunit of Escherichia coli. , 1978, Biochemistry.

[101]  X. Jacq,et al.  Ribosomal protein S7 is both a regulator and a substrate of MDM2. , 2009, Molecular cell.

[102]  M. Kubbutat,et al.  Regulation of HDM2 activity by the ribosomal protein L11. , 2003, Cancer cell.

[103]  J. Royds,et al.  Y-box factor YB1 controls p53 apoptotic function , 2005, Oncogene.

[104]  Karen H. Vousden,et al.  Modifications of p53: competing for the lysines. , 2009, Current opinion in genetics & development.

[105]  Y Taya,et al.  A role for ATR in the DNA damage-induced phosphorylation of p53. , 1999, Genes & development.

[106]  A. Strasser,et al.  How important are post-translational modifications in p53 for selectivity in target-gene transcription and tumour suppression? , 2007, Cell Death and Differentiation.